×

Pharmaceutical formulations of amyloid inhibiting compounds

  • US 20060251714A1
  • Filed: 04/12/2006
  • Published: 11/09/2006
  • Est. Priority Date: 04/12/2005
  • Status: Abandoned Application
First Claim
Patent Images

1. An oral formulation comprising an active agent which is 3-amino-1-propanesulfonic acid or a pharmaceutically acceptable salt thereof in an amount effective to treat or prevent Alzheimer'"'"'s disease and/or Cerebral Amyloid Angiopathy (CAA), and a pharmaceutically acceptable vehicle, wherein, when the formulation is administered to a subject, a mean plasma concentration profile of the active agent having a mean AUC

  • of about from 814 to 6604 ng·

    h/mL and a mean Cmax of about from 137 to 1235 ng/mL is achieved.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×